pxs135

Patrick J. Shenot, MD, FACS

Contact Dr. Shenot

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

215-955-6961
215-923-1884 fax

Most Recent Peer-reviewed Publications

  1. Iatrogenic bladder rupture in individuals with disability related to spinal cord injury and chronic indwelling urethral catheters
  2. The Evidence For and Against Prostate-Reducing Procedures for Men with Neurogenic Bladder
  3. Faculty Development: How Do We Encourage Faculty to Become Better Teachers and Mentors?
  4. Next-generation DNA sequencing for infected genitourinary implants: How I do it
  5. Stress urinary incontinence post-holmium laser enucleation of the prostate: A single-surgeon experience
  6. Industry payments to female pelvic medicine and reconstructive surgeons: an analysis of Sunshine Act open payments from 2014–2017
  7. Hospital-specific antibiograms and antibiotic prophylaxis for prostate biopsies: a reexamination of AUA recommendations
  8. Female Representation at High-profile Urology Conferences, 2014-2019: A Leadership Metric
  9. Urinary undiversion by conversion of the incontinent ileovesicostomy to augmentation ileocystoplasty in spinal cord injured patients
  10. A retrospective comparison of diode to holmium for laser enucleation of the prostate
  11. Making the case for enterocystoplasty in the urologic management of patients with multiple sclerosis
  12. Knowledge Gaps in Urologic Care of Female Spinal Cord Injury Patients
  13. Medial Renal Ptosis: First Radiographic Documentation With Computed Tomography
  14. Leaders in Urologic Education and Their Relationship to Industry: An Analysis of Sunshine Act Open Payments From 2014-2016
  15. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
  16. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study
  17. Botulinum Toxin A: Evolving Treatment Strategies for the Chronic Pelvic Pain Patient
  18. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
  19. Ureteroarterial fistula: A review of the literature
  20. The effects of fatigue on robotic surgical skill training in Urology residents
  21. Intradetrusor onabotulinumtoxinA injection: How I do it
  22. OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity
  23. Office-based Care of the Neurogenic Bladder Patient
  24. Uropharmacology in primary care: 2010 update
  25. Update on neuromodulation for frequency, urgency, retention, and neurogenic voiding dysfunction